Clinical experience of tabelecleucel in patients with EBV+ primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease Meeting Abstract


Authors: Nikiforow, S.; Baiocchi, R.; Nasta, S.; Weng, W.; Loeb, D.; Mahadeo, K. M.; Whangbo, J.; Phuong, P.; Navarro, W.; Gamelin, L.; Sun, Y.; Guzman-Becerra, N.; Prockop, S.
Abstract Title: Clinical experience of tabelecleucel in patients with EBV+ primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S719
Language: English
ACCESSION: WOS:000573469101339
DOI: 10.1016/j.annonc.2020.08.1171
PROVIDER: wos
Notes: Meeting Abstract: 1051P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan E Prockop
    262 Prockop